Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 20, 2016
Patent Application Number
14126296
Date Filed
June 13, 2012
Patent Primary Examiner
Patent abstract
Compounds as defined herein are provided which are useful in (1) diagnostic methods for detecting and/or identifying cells presenting PSMA; (2) compositions comprising a compound of the invention together with a pharmaceutically acceptable diluent; and (3) methods for imaging prostate cancer cells.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
